一个sarcopenia查测试预测住院癌症患者的死亡率
Wen-Li Lin1,2, Jyh-Jou Chen3, Li-Min Wu4,5
1Department of Medical Affairs, Chi Mei Medical Center, Tainan, Liouying, Taiwan.
Physiological reports
|August 6, 2024
概括
Sarcopenia 查准确预测癌症住院患者的死亡率. 该工具有助于识别高风险个体,以获得更好的住院护理和生存结果.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 临床营养学 临床营养学
背景情况:
- 标志着肌肉质量和功能丧失的萨尔科佩尼亚在癌症患者中很普遍.
- 预测住院癌症患者的死亡风险对于及时干预和护理管理至关重要.
研究的目的:
- 调查一项针对癌症住院患者的总生存期 (OS) 和全因死亡率的 Sarcopenia查测试的预测能力.
- 为了识别与这种人群中的肉类和死亡率相关的因素.
主要方法:
- 这是一项前性研究,涉及台湾82名癌症住院患者.
- 综合评估包括东部合作瘤学集团 (ECOG) 的绩效状况,认知能力,营养指数,体重指数和短物理性能电池 (SPPB).
- 对患者进行了3年的随访,以评估生存状况和死亡率.
主要成果:
- 在64.6%的参与者中诊断出了sarcopenia,并且与明显更糟糕的OS有关.
- 转移和低专辑蛋白水平是OS的独立预测因素.
- 年龄预测2年死亡率在65岁以上的患者中.
结论:
- Sarcopenia 查是预测OS和癌症住院患者全因死亡率的宝贵工具.
- 结果可以帮助患者分层和优化医院内护理策略.
- Sarcopenia 的早期识别可能会改善患者的治疗结果和生存率.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Kaplan-Meier Approach
115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115


